Galmed Pharma Cash Flow - Annual (NASDAQ:GLMD)

Add to My Stocks
$11.64 $0.27 (2.37%) GLMD stock closing price Oct 12, 2018 (Closing)

The Galmed Pharma cash flow statement is one of the three reports that the company generates every quarter. The profit-loss statement shows Galmed Pharma profits, the balance sheet shows Galmed Pharma debt, and the cash flow statement reflects the liquidity and solvency of a firm. This statement reflects the company's ability to generate cash flows. Galmed Pharma cash flow analysis is possible because this statement breaks down how balance sheet accounts and income statement items affect cash and cash equivalents. Galmed Pharma had cash and cash equivalents of $3.09M at the beginning of the year and $13.02M at year end for 2017. Galmed Pharma has a positive cash and cash equivalents change of $9.92M.

View details of Galmed Pharma cash flows for latest & last 10 financial years
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec201720162015201420132012
Net Income Cash Flow
-12.29M-16.95M-10.62M-9.1M-17.48M-3.14M
Depreciation Depletion Amortization Cash-Flow------
Net Increase (Decrease) in Assets Liabilities-1.39M2.75M--0.74M1.21M-0.14M
Cash From (used in) Discontinued Operations------
Other Adjustments Net1.37M1.85M1.02M-13.73M-
Net Cash from (used by) Operating Activities
-12.06M-12.12M-8.47M-9.24M-2.52M-3.07M
Increase (Decrease) in Prop Plant And Equipment-0.01M--0.15M-0.77M--0.03M
Acquisition Disposition of Subsidiaires------
Increase (Decrease) in Investments6.45M6.34M-10.94M-8.24M--
Other Cash Inflow (Outflow) from Investment Activities------
Net Cash from (used by) Investment Activities
6.44M6.33M-11.1M-9.01M--0.03M
Issuance (Purchase) of Equity Shares15.54M4.73M-41.85M--
Issuance (Repayment) of Debt Securities------
Increase (Decrease) in Bank & Other Borrowings----1.82M-
Payment of Dividends & Other Cash Distributions------
Other Cash from (used by) Financing Activities-----3.66M
Net Cash from (used by) Financing Activities
15.54M4.73M-41.85M1.94M3.68M
Effect of Exchange Rate Changes on Cash------
Net Change in Cash & Cash Equivalents
9.92M-1.05M-19.58M23.59M-0.58M-
Cash & Equivalents at Beginning of Year3.09M4.15M23.73M---
Cash & Equivalents at Year End13.02M3.09M4.15M23.73M--
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The Galmed Pharma stock price history and Galmed Pharma stock comparison chart inevitably reflect its cash flow situation.

  • Galmed Pharma had a Net Change in Cash and Cash Equivalents of $9.92M for the latest year 2017. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the Galmed Pharma stock price, albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Cash Flow from operating activities: Galmed Pharma reported a negative operating cash flow of $-12.06M for 2017 and has seen an increase from the previous year. Operating cash flow comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $6.44M for GLMD in last 2017 report.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $15.54M for Galmed Pharma.

Key Financial Ratios For Galmed Pharma Cash Flow